Is high-intensity focused ultrasound (HIFU) an option for neoadjuvant therapy for borderline resectable pancreatic cancer patients? – a systematic review

Figures & data

Figure 1. Study diagram according to Medline database: screening, eligibility, included.

Figure 2. Study diagram according to Wanfang database: screening, eligibility, included.

Table 1. Studies met the inclusion criterias of the review.

Author	Cases	Age	HIFU + Chemo	HIFU	Time to surgery	Number of surgery	R0 resection	R1 resection	Survival time
Zhao et al.	37	55	39	–	N.R.	5	4	1	N.R.
Sofuni et al.	30	64,3 ± 1.5	28	N.R.	N.R.	2	N.R.	N.R.	N.R.
Wang et al.	30	57	–	30	7–9 days	27	25	2	92.7%−1 year